• Users Online: 58
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
ORIGINAL ARTICLE
Year : 2012  |  Volume : 24  |  Issue : 2  |  Page : 37-42

Cardiovascular changes in dipper and nondipper hypertension in perimenopausal women ( time-dependent effects of antihypertensives)


1 Department of Cardiology, Mansoura Faculty of Medicine, Mansoura, Egypt
2 Department of Obstetric and Gynecology, Mansoura Faculty of Medicine, Mansoura, Egypt
3 Department of Internal Medicine, Mansoura Faculty of Medicine, Mansoura, Egypt
4 Department of Radiology, Mansoura Faculty of Medicine, Mansoura, Egypt
5 Department of Clinical Pathology, Mansoura Faculty of Medicine, Mansoura, Egypt

Date of Submission15-May-2012
Date of Acceptance15-Jun-2012
Date of Web Publication16-Jul-2014

Correspondence Address:
Wael Ragheb Refaie
Department of Cardiology, Mansoura Faculty of Medicine, Mansoura
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.7123/01.EJIM.0000419545.12615.3e

Rights and Permissions
  Abstract 

Background

The lack of a decrease in nocturnal blood pressure to up to 10% of the daytime measure is termed as nondipper (ND) hypertension. It is a cardiovascular (CV) risk factor with increased CV morbidity and accelerated target organ damage especially in women. The beneficial effect of restoring the ND state by administering antihypertensives (chronotherapy) at bedtime rather than on awakening is still debated.

Objectives

The aim of this study was to determine the extent of ND hypertension and the magnitude of CV morbidities among perimenopausal women in comparison with an identical dipper group. The study also intended to determine the administration time-dependent effect on the ND state.

Study design

The study included a cross-sectional part and a prospective randomized part.

Patients and methods

One hundred and thirty perimenopausal women who were not known to be hypertensive, with an office blood pressure repeatedly exceeding 140/90 mmHg were included. After obtaining informed consents, complete history was taken and clinical examination was carried out. The included patients underwent 12-lead ECG and echocardiography, and the carotid intima–media thickness was measured. Besides the routine urine and blood analysis, analyses to obtain levels of lipids, HbA1-c, serum thyroid stimulating hormone, coagulation factors (factor VIII, fibrinogen), urinary albumin excretion, and C reactive protein were also carried out. Ambulatory blood pressure of all patients on a nonworking day was monitored. The studied patients were classified as dippers and NDs. The ND patients were randomly assigned to treatment with angiotensin receptor blockers (ARBs). Half of the ND patients received their dosage at bedtime and the others received the same dosage on awakening for 6 months, after which the ambulatory blood pressure was remeasured.

Results

ND hypertension was detected in 61.5% of patients, its occurrence being significantly higher among women with hot flashes, those with postural hypotension, obese women, and among women with elevated HbA1-c, fibrinogen, cholesterol, C reactive protein and urinary albumin excretion levels. There was significant prolongation of the QTc interval and QT dispersion with a significant increase in the interventricular septal dimension and carotid artery intima-media thickness in the ND group. Disappearance of the ND phenomenon occurred in 80% of patients receiving therapy with ARBs at bedtime.

Conclusion

ND hypertension is common among perimenopausal women, especially those with hot flashes, postural hypotension, and higher BMIs and HbA1-c levels, and is associated with many CV risk factors. Chronotherapy with ARBs at bedtime is more efficient in restoring the circadian rhythm of blood pressure compared with that on awakening.

Keywords: chronotherapy, dipper, nondipper


How to cite this article:
Refaie WR, Refaie E, El Hady NA, Tantawy S, Elewa A. Cardiovascular changes in dipper and nondipper hypertension in perimenopausal women ( time-dependent effects of antihypertensives). Egypt J Intern Med 2012;24:37-42

How to cite this URL:
Refaie WR, Refaie E, El Hady NA, Tantawy S, Elewa A. Cardiovascular changes in dipper and nondipper hypertension in perimenopausal women ( time-dependent effects of antihypertensives). Egypt J Intern Med [serial online] 2012 [cited 2019 Jul 23];24:37-42. Available from: http://www.esim.eg.net/text.asp?2012/24/2/37/136012


  Introduction Top


Cardiovascular diseases (CVD) are the main cause of morbidity and mortality worldwide. Hypertension is one of the major traditional risk factors for CVD. Despite the availability of many groups of antihypertensives, hypertension is well controlled only in 6–25% of patients 1.

In healthy as well as hypertensive individuals there is a diurnal variation in blood pressure (BP) levels, with a 10–20% decrease during the night. Patients without a nocturnal (sleep) decline in BP to at least 10% of the daytime measure are referred to as nondippers (NDs) 2. The classification of hypertension as dipper and ND is a relatively recent one dating back to the end of 1990, when Perloff and colleagues published their first seminal on awake ambulatory BP being a predictor of cardiovascular (CV) outcome 3–5.

There is substantial evidence indicating that night-time BP is a more powerful predictor of CV morbidity and mortality compared with conventional office or ambulatory daytime BP levels and that the ND pattern of hypertension is an added novel risk factor that has been associated with accelerated target organ damage (TOD) 6–9. Although good BP control is one of the recommended targets in the management of hypertension 10, detection of the ND state is not universally applied and ambulatory BP monitoring (ABPM) is not even accepted as a clinical procedure in some countries 5. Magnanini et al. 11 concluded that it is mandatory to use ABPM to evaluate, control, and guide therapeutic strategies in hypertension. Whether it is necessary to specify hypertension as dipper or ND by 24, 48 h, or 7 days of ABPM is not settled 5.

Chronotherapy is a new pharmacologic concept in which medications are delivered at a time and concentration that varies according to physiologic need during the dosing period. Although most types of CVDs follow a circadian (24-h) pattern 12, the use of chronotherapy for hypertension continues to lag despite many studies indicating that bedtime administration of conventional antihypertensive medication exerts better BP control and CVD risk reduction compared with the traditional approach of morning medication 13.

The ND phenomenon is more prevalent in hypertensive women who are also at a greater risk of TOD compared with ND hypertensive men, especially those under treatment with NSAIDs 14,15. Past history of adverse pregnancy outcome and present history of hot flashes in hypertensive perimenopausal women involves a higher risk for ND hypertension and TOD 16,17.

Objectives

The aim of this study was to identify the extent of ND hypertension among previously untreated perimenopausal women with repeated office BP of at least 140/90 mmHg and to elucidate the CV risk factors and comorbidities in a group of women with dipper hypertension versus an identical group of women with ND hypertension.

Design

The study contains an observational cross-sectional part and a prospective comparative part.


  Subjects and methods Top


One hundred and thirty perimenopausal women with ages ranging from 46.5 to 54.5 years (not known to be hypertensive nor under previous treatment) presenting at the Mansoura University Outpatient Clinics with nonspecific symptoms such as fatigability, weakness, occasional hot flushes, and oligo or amenorrhea, and with a repeated office BP measurement of at least 140/90 mmHg were recruited. Office BP in the sitting and standing positions was measured using a calibrated mercury sphygmomanometer with an appropriately sized cuff. Two BP measurements 5 min apart and the last reading were considered. After approval of the scientific committee and obtaining informed consent, the examined patients were subjected to complete clinical examination, stressing on history of previous adverse pregnancy outcome, hot flushes, and symptoms suggestive of CV, renal, and retinal affection. Detailed physical examination including estimation of BMI and waist circumference midway between the costal margin and iliac crest was carried out. CV examination including estimation of heart rate, arterial pulsation, edema, cardiac size, and cardiac bruit, as well as abdominal and fundoscope examination, were undertaken. The examined cases were classified as grade I and grade II hypertension according to the European Society of Hypertension, Society of Cardiology Guideline Committee 18.

Exclusion criteria

Patients with suspected secondary hypertension, resistant hypertension, known or treated diabetes mellitus, collagen diseases, vasculities, morbid obesity, depression, chronic obstructive pulmonary disease, sleep apnea syndrome, hepatic or renal dysfunction, or endocrinopathies were excluded.

The studied patients were subjected to 12-lead electrocardiograms, stressing on ischemic changes, ventricular dominance, arrhythmia, QTc intervals, and QT dispersion. Doppler echo cardiography stressing on measurement of interventricular septal diameter and interventricular septal thickness (IVST), and estimation of ventricular systolic and diastolic dysfunction was performed applying the criteria of the American Society of Echocardiography for left ventricular hypertrophy; left ventricular mass index (LVMI) greater than 104 g/m2 was obtained 19. LVM was calculated according to the procedure adopted by Devereux et al. 20 and was normalized for body surface area to obtain LVMI. The echo cardiographic procedures were conducted by an observer who was unaware of the dipper or nondipper state.

Carotid ultrasonography was performed for estimation of carotid intima–media thickness (CIMT) with stress on its diameter and presence or absence of atheromatous plaques and their characteristics. Ambulatory blood pressure was monitored for 24 h on a nonworking day; the intervals between measurements were 20 min during diurnal periods and 30 min during nocturnal periods 10.

All patients were subjected to 24-h urine collection and analysis for microalbuminuria; complete blood count, stressing on platelet count; and complementary analyses including estimation of levels of lipids (plasma cholesterol, triglycerides, HDL-cl), HbA1-c, factor VIII, and C reactive protein (normally <5 mg/l).

On analyzing the results from ABPM, 80 patients were found to be NDs and 50 patients were dippers. The ND patients were treated using angiotensin receptor blockers (ARBs; 160 mg valsartan); 40 patients received the medication at bedtime and the other 40 received the same dosage on awaking in the morning. The patients were followed up for 6 months; results of ABPM were rechecked and comparisons were made between patients receiving valsartan at bedtime and those receiving valsartan in the morning. CIMT values were also compared.

Statistical analysis

Statistical analysis was performed using SPSS version 16 (SPSS Inc., Chicago, Illinois, USA). Qualitative data were presented as frequency and percentages. Quantitative data were examined using the Kalmogrov–Smirnov test to test for normal distribution of the data and, when parametric, were expressed as mean and SD. Student’s t-test was used to compare differences in normally distributed quantitative data between the two groups. The Mann–Whitney U-test was used for comparison between two groups when the data were not normally distributed. A P-value less than 0.05 was considered significant.


  Results Top


ND hypertension was detected in 61.5% of the studied patients, its occurrence being significantly higher among women with hot flushes, adverse pregnancy outcomes, obese women, those with postural hypotension, fatty liver, elevated levels of HbA1-c, fibrinogen, cholesterol, and triglycerides, and those with increased microalbuminuria and CRP levels [Table 1] and [Table 2].
Table 1: Clinical characteristics of the studied dipper and nondipper hypertensive groups

Click here to view
Table 2: Biochemical characteristics of the studied dipper and nondipper hypertensive groups

Click here to view


In the ND group, there was significant QTc prolongation and frequent QT dispersion. The CIMT revealed significant broadening in the ND group [Table 3], which was significantly reduced on treatment with valsartan and was further reduced by evening dosages [Table 4] and [Table 5]. After 6 months of ARB treatment, there was significant restoration of the dipping state in 80% of the studied patients receiving valsartan at bedtime versus 30% of those treated with valsartan in the morning [Table 5].
Table 3: Electrocardiographic, echocardiographic and carotid intima–media thickness among the studied groups

Click here to view
Table 4: Chronotherapy and restoration of the dipping state

Click here to view
Table 5: Chronotherapy and carotid intima–media thickness

Click here to view



  Discussion Top


Although the classification of hypertensive patients into dipper and ND groups is relatively recent 4, 5, substantial evidence indicates that night-time hypertension is a more powerful predictor of CV morbidities and TOD 7–9. Hypertension with a circadian nocturnal ND pattern seems to be relatively common. In the present randomized study, about two-third (61%) of the first-discovered grade I/II hypertensive perimenopausal women were found to be NDs. Sierra et al. 21 reported 40.2% of patients to be NDs and 13.4% to show a nocturnal rise in BP. Khromtsova 22 reported 56% of patients to be NDs. Mediavilla Garcoa et al. 23 reported that 49.6% of patients were NDs and 9.4% showed a nocturnal rise in BP. Gorostidi et al. 24 found the prevalence of the ND pattern to be 60% higher in high risk hypertensive patients, that is they support the recommendation of a wider use of ABPM.

In the present study, patients with associated conditions that lead to ND hypertension were excluded, for example those with diabetes mellitus 25, depression 26, sleep apnea syndrome 27, collagen disease, hemorrhagic vasculitis 28, chronic obstructive lung disease 29, and kidney disorders.

In Egypt hypertension is an endemic phenomenon (26.3%), being one of the most common risk factors for CVD. Hypertension in more than three-fourth of the patients is uncontrolled 30. Cuspida et al. 31 reported that hypertension in only 6–25% of patients is controlled. Night-time hypertension was found to be a more powerful predictor of CV morbidity and mortality, which led to the consideration of the ND pattern of hypertension as an added novel risk factor 6. Kulakov and Nasonova 32 found that ND hypertension is significantly higher in warm moist weather (cyclonic) like that in Egypt (in summer and spring months). Excessive intake of salts can also cause ND hypertension 33. Egypt is one of the oriental countries with the population known to prefer food with a higher salt content. It may be speculated that the ND phenomenon is more frequent in Egypt because of its hot weather 32, high salt intake 33 and the habit of common use of pro hypertensive NSAIDS 14. However this speculation awaits further confirmation.

In the present study, women with hot flushes and previous history of adverse pregnancy outcomes reported a high rate of ND hypertension. This is in accordance with studies by Gerrie Cor et al. 16, Ben-Ami et al. 34, and Hart et al. 17. The control of BP in women with hot flushes needs identification of their nocturnal BP circadian pattern and specific chronotherapy.

Patients with orthostatism showed greater probability of nocturnal hypertension [Table 1]. This is in agreement with the study by Carmona et al. 35 who concluded that orthostatism corresponds to a greater probability of nocturnal hypertension and thus selecting patients to undergo 24 h ABPM.

In the present study, a significant increase in microalbuminuria was detected in the ND group [Table 2]. This is in agreement with the study by Cobuz and Datch 36 who found that an early increase in nocturnal systolic blood pressure has key role in tracking the progression of nephropathy. Davidson et al. 37 found that the rate of decline in glomerular filtration rate is an important factor in ND hypertension.

Factor VIII was increased in the ND group, and this is in accordance with the findings of Agorasti et al. 38. Similarly, plasma fibrinogen was significantly higher in the ND group when compared with the dipper group. This is in accordance with the study by Hermida et al. 39, who found that patients with ND hypertension showed significantly higher levels of plasma fibrinogen throughout the year. The ND group in the present work revealed significant hyperlipidemia hypercoagulability , hyperuricemia, and increased levels of inflammatory marker, which are commonly associated with accelerated atherosclerosis and a tendency for hypertension emergencies.

In the present study, QTc was more prolonged with more evident QTd in the ND hypertension group compared with the dipper hypertension group The ND hypertension state could predispose an individual to cardiac arrhythmia and sudden death 40. Patients with ND hypertension had a significantly higher incidence of LVMI and left ventricular diastolic dysfunction attributed to HTN (ND) [Table 3], which is in agreement with the findings of Ersoylin et al. 41, who also found an increase in aortic root diameter, end diastolic IVST, and LVP wall thickness in patients with ND hypertension. The present findings also coincide with the findings of Cuspidi et al. 1, who found that LVMI and IVST were significantly higher in the ND group.

Individuals with ND hypertension, especially women, are at a greater risk for TOD 15,40. Hermida et al. 42 showed that patients with the ND pattern represent a risk factor for left ventricular hypertrophy. However, our results and many of the aforementioned studies are not in agreement with the studies by Gonzailez Quijada et al. 43 and Cuspidi et al. 44 who reported no significant difference in LVM between dipper and ND groups and reported that ND-treated hypertensive patients did not have increased cardiac structural changes.

Our results of significant conversion of the ND state to the dipper state by nocturnal administration of ARBs is confirmatory of the findings of the recent MAPEC study 13, which reported that bedtime administration of conventional medications exert better BP control and CV risk reduction compared with the traditional approach of scheduling all medications in the morning. In the present study [Table 4], 80% of patients with ND hypertension became dippers on following the regimen of administration of ARBs at bedtime. Our results are in accordance with those of many other previous studies that revealed the beneficial effects of administering ARBs, angiotensin converting enzyme inhibitors, calcium channel blockers, and other antihypertensive drug therapies at bedtime in ND hypertensive patients 1, 45, 46. Chronotherapy with valsartan improved BP during sleep and restored the diurnal rhythm in adequately controlled ND hypertensives with bedtime dosing 47. Similarly, dosing with captopril at night was reported to restore the diurnal rhythm in patients with adequately controlled ND hypertension 48.


  Conclusion Top


ND hypertension is frequent in perimenopausal women, especially the obese ones with hot flushes and/or postural hypotension. This is associated with ominous CV changes that may put the patients at a higher risk for CV disease. Chronotherapy with night dosing hypotensives is of greater value in ND patients. The use of ABPM strategies is needed to detect ND states of hypertension, and patients with ND hypertension should be meticulously investigated and monitored for CV dysfunctions.[48]

 
  References Top

1.Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004;22:273–280  Back to cited text no. 1
    
2.Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, Guerrini E. “Non-dipper” hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol. 1995;43:382–387  Back to cited text no. 2
    
3.White WB. Ambulatory blood pressure as a predictor of target organ disease and outcome in the hypertensive patient. Blood Press Monit. 1999;4:181–184  Back to cited text no. 3
    
4.Zhu Y, Xu H, Tian H, Zhou LJ, Cao Q, Shen Q, Sun L. Ambulatory blood pressure monitoring in pediatric patients with kidney diseases. Zhonghua Er Ke Za Zhi. 2008;46:374–377  Back to cited text no. 4
    
5.Otsuka K. Seven-day (24-hour) ambulatory blood pressure monitoring and frequently observed day-to-day differences in the elderly. Nihon Ronen Igakkai Zasshi. 2009;46:488–492  Back to cited text no. 5
    
6.Syrseloudis D, Tsioufis C, Andrikou I, Mazaraki A, Thomopoulos C, Mihas C, et al. Association of nighttime hypertension with central arterial stiffness and urinary albumin excretion in dipper hypertensive subjects. Hypertens Res. 2011;34:120–125  Back to cited text no. 6
    
7.Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension. 2000;36:894–900  Back to cited text no. 7
    
8.Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006;19:243–250  Back to cited text no. 8
    
9.Yoon SY, Pyun WB. Clinical significance of nighttime blood pressure. Korean J Med. 2011;80:31–35  Back to cited text no. 9
    
10.Kanoun F, Ben Alaya N, Idriss S, Sayem N, Chihaoui M, Harzallah F, Slimane H. Ambulatory blood pressure measurement and control in hypertensive diabetic patients. Tunis Med. 2010;88:885–889  Back to cited text no. 10
    
11.Magnanini MM, Nogueira Ada R, Carvalho MS, Bloch KV. Ambulatory blood pressure monitoring and cardiovascular risk in resistant hypertensive women. Arq Bras Cardiol. 2009;92:448–453 467–472, 484–489  Back to cited text no. 11
    
12.White WB. Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press Monit. 2000;5(Suppl 1):S17–S23  Back to cited text no. 12
    
13.Portaluppi F, Smolensky MH. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol Int. 2010;27:1652–1667  Back to cited text no. 13
    
14.Lazebnik LB, Kotsiubinskaia OB, IuV Konev, Drozdov VN. Non-steroidal anti-inflammatory drugs and tramadol in the treatment of osteoarthrosis deformans in patients with arterial hypertension. Klin Med (Mosk). 2004;82:56–61  Back to cited text no. 14
    
15.Routledge FS, McFetridge-Durdle JA, Dean CR. Stress, menopausal status and nocturnal blood pressure dipping patterns among hypertensive women. Can J Cardiol. 2009;25:e157–e163  Back to cited text no. 15
    
16.Gast GM, Grobbee DE, Pop VJM, Keyzer JJ, Gent CJMW, Samsioe GN, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension. 2008;51:1492–1498  Back to cited text no. 16
    
17.Hart EC, Charkoudian N, Miller VM. Sex, hormones and neuroeffector mechanisms. Acta Physiol (Oxf). 2011;203:155–165  Back to cited text no. 17
    
18.. 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011–1053  Back to cited text no. 18
    
19.Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367  Back to cited text no. 19
    
20.Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458  Back to cited text no. 20
    
21.Sierra C, De la Sierra A, Sobrino J, Segura J, Banegas JR, Gorostidi M. Ruilope [ambulatory blood pressure monitoring (CABPM): clinical characteristics of 31,530 patients]. Med Clin (Barc). 2007;129:1–5  Back to cited text no. 21
    
22.Khromtsova OM. Individual chronotherapy of essential hypertension and compliance of patients with treatment scheme]. Ter Arkh. 2008;80:29–33  Back to cited text no. 22
    
23.Mediavilla Garcoa JD, Fernondez-Torres C, Arroyo A, Jimonez-Alonso J. Study of the circadian blood pressure profile in patient with arterial hypertension. An Med Interna. 2007;24:61–66  Back to cited text no. 23
    
24.Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernondez del Rey R, et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25:977–984  Back to cited text no. 24
    
25.Izzedine H, Launay-Vacher V, Deray G. Abnormal blood pressure circadian rhythm: a target organ damage? Int J Cardiol. 2006;107:343–349  Back to cited text no. 25
    
26.Scuteri A, Spalletta G, Cangelosi M, Gianni W, Assisi A, Brancati AM, et al. Decreased nocturnal systolic blood pressure fall in older subjects with depression. Aging Clin Exp Res. 2009;21:292–297  Back to cited text no. 26
    
27.Sekizuka H, Kida K, Akashi YJ, Yoneyama K, Osada N, Omiya K, Miyake F. Relationship between sleep apnea syndrome and sleep blood pressure in patients without hypertension. J Cardiol. 2010;55:92–98  Back to cited text no. 27
    
28.Shilkina NP, Iunonin IE, Stoliarova SA, Driazhenkova IV. Arterial hypertension in patients with systemic connective tissue diseases and hemorrhagic vasculitis. Ter Arkh. 2010;82:40–45  Back to cited text no. 28
    
29.Ol’binskaia LI, Belov AA. 24-Hour arterial pressure profile in chronic obstructive lung diseases in combination with arterial hypertension treated with enalapril. Ter Arkh. 2002;74:59–62  Back to cited text no. 29
    
30.Ibrahim MM, Rizk H, Apple LJ. The NHP investigation team. Hypertension, prevalence, awareness, treatment and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). Hypertension. 1995;26:880  Back to cited text no. 30
    
31.Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens. 2001;9:2063–2070  Back to cited text no. 31
    
32.Kulakov IuV, Nasonova EV. The specific features of circadian blood pressure variations in patients with hypertensive disease in different types of weather. Klin Med (Mosk). 2004;82:24–27  Back to cited text no. 32
    
33.Uzu T, Sakaguchi M, Yokomaku Y, Kume S, Kanasaki M, Isshiki K, et al. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker. Clin Exp Nephrol. 2009;13:300–306  Back to cited text no. 33
    
34.Ben-Ami S, Oron G, Ben-Haroush A, Blickstein D, Hod M, Bar J. Primary atherothrombotic occlusive vascular events in premenopausal women with history of adverse pregnancy outcome. Thromb Res. 2010;125:124–127  Back to cited text no. 34
    
35.Carmona J, Amado P, Vasconcelos N, Almeida L, Santos I, Alves J, Nazaro J. Does orthostatic hypotension predict the occurrence of nocturnal arterial hypertension in the elderly patient? Rev Port Cardiol. 2003;22:607–615  Back to cited text no. 35
    
36.Cobuz C, Datcu G. Relationship of hypertension and microalbuminuria in type 1 diabetes. Rev Med Chir Soc Med Nat Iasi. 2010;114:52–58  Back to cited text no. 36
    
37.Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med. 2006;166:846–852  Back to cited text no. 37
    
38.Agorasti A, Mourvati E, Trivellas T, Papadopoulos V, Bazntiara I, Christoforidou A, Passadakis P. Changes in haemostatic and platelet activation markers in non-dipper hypertensive patients. Int Urol Nephrol. 2012;44:523–533  Back to cited text no. 38
    
39.Hermida RC, Calvo C, Ayala DE, Lopez JE, Fernandez JR, Mojon A, et al. Seasonal variation in plasma fibrinogen in dipper and non-dipper patients with mild-moderate essential hypertension. Med Clin (Barc). 2003;121:6–11  Back to cited text no. 39
    
40.Voiculescu M, Ionescu C, Ismail G. Frequency and prognostic significance of QT prolongation in chronic renal failure patients. Rom J Intern Med. 2006;44:407–417  Back to cited text no. 40
    
41.Ersoylu ZD, Tuocu A, Yildirimtork O, Aytekin V, Aytekin S. Comparison of the incidences of left ventricular hypertrophy, left ventricular diastolic dysfunction, and arrhythmia between patients with dipper and non-dipper hypertension. Turk Kardiyol Dern Ars. 2008;36:310–317  Back to cited text no. 41
    
42.Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 2007;59:904–922  Back to cited text no. 42
    
43.Gonzolez Quijada S, Grande Soez MC, Dueñas Gutiorrez C, Ceballos Baron MI, Marton Ezquerro A, Sevil Puras M, Blanco Garcoa M. Cardiovascular and hormonal factors associated with the lack of nocturnal fall in blood pressure among individuals aged over 55. Rev Clin Esp. 2002;202:264–268  Back to cited text no. 43
    
44.Cuspidi C, Michev I, Meani S, Valerio C, Bertazzoli G, Magrini F, Zanchetti A. Non-dipper treated hypertensive patients do not have increased cardiac structural alterations. Cardiovasc Ultrasound. 2003;1:1  Back to cited text no. 44
    
45.Kario K. Proposal of RAS-diuretic vs. RAS-calcium antagonist strategies in high-risk hypertension: insight from the 24-hour ambulatory blood pressure profile and central pressure. J Am Soc Hypertens. 2010;4:215–218  Back to cited text no. 45
    
46.Hermida RC, Ayala DE, Fontao MJ, Mojon A, Fernandez JR. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int. 2010;27:1287–1303  Back to cited text no. 46
    
47.Hermida RC, Ayala DE, Mojon A, Fontao MJ, Fernandez JR. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int. 2011;28:601–610  Back to cited text no. 47
    
48.Qiu YG, Zhu JH, Tao QM, Zheng P, Chen JZ, Hu SJ, et al. Captopril administered at night restores the diurnal blood pressure rhythm in adequately controlled, nondipping hypertensives. Cardiovasc Drugs Ther. 2005;19:189–195  Back to cited text no. 48
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Subjects and methods
Results
Discussion
Conclusion
Introduction
Subjects and methods
Results
Discussion
Conclusion
References
Article Tables

 Article Access Statistics
    Viewed1138    
    Printed26    
    Emailed0    
    PDF Downloaded100    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]